Zydus And Synthon Sign US Ibrance Generic Deal With Potential Exclusivity

Synthon And Pfizer Settle US Patent Infringement Claims Over $3.1bn Palbociclib Brand

 
• By Urtė Fultinavičiūtė
  
Deal handshake agreement document
The paragraph IV certification may grant a six-month market exclusivity • Source: Shutterstock

More from Deals

More from Business